Skip to main content
. 2022 Mar 24;27(7):536–e553. doi: 10.1093/oncolo/oyab080
Completion Study terminated before completion
Reason terminated Toxicity
Investigator’s Assessment Due to dose-limiting skeletal muscle toxicities and the lack of efficacy at the maximum tolerated dose of 100 mg, further enrollment was stopped.